June 27, 2022
MENLO PARK, Calif., June 22, 2022 /PRNewswire/ — Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank, alongside plans to construct a new pilot scale biomanufacturing facility. The financing will support Antheia’s expansion with a 14,700 square-foot pilot plant located next to Antheia’s headquarters in Menlo Park, CA. FLG partner, Patrick Nugent assisted.
Full press release is here.